TY  - GEN
AU  - Batich,Kristen A
AU  - Reap,Elizabeth A
AU  - Archer,Gary E
AU  - Sanchez-Perez,Luis
AU  - Nair,Smita K
AU  - Schmittling,Robert J
AU  - Norberg,Pam
AU  - Xie,Weihua
AU  - Herndon,James E
AU  - Healy,Patrick
AU  - McLendon,Roger E
AU  - Friedman,Allan H
AU  - Friedman,Henry S
AU  - Bigner,Darell
AU  - Vlahovic,Gordana
AU  - Mitchell,Duane A
AU  - Sampson,John H
TI  - Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
SN  - 1557-3265
PY  - 2017///0627
KW  - Adjuvants, Immunologic
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Brain Neoplasms
KW  - immunology
KW  - Cancer Vaccines
KW  - Combined Modality Therapy
KW  - Dacarbazine
KW  - administration & dosage
KW  - Dendritic Cells
KW  - Disease-Free Survival
KW  - Female
KW  - Glioblastoma
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Phosphoproteins
KW  - T-Lymphocytes, Regulatory
KW  - Temozolomide
KW  - Viral Matrix Proteins
N1  - Publication Type: Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-16-2057
ER  -